Ignite Creation Date:
2025-12-25 @ 4:28 AM
Ignite Modification Date:
2026-05-10 @ 4:17 PM
Study NCT ID:
NCT01044420
Status:
UNKNOWN
Last Update Posted:
2010-01-07
First Post:
2010-01-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
mFOLFIRI as the Second Line Chemotherapy for Advanced Esophageal Carcinoma After Failure of 1st Line Treatment of Paclitaxel/DDP : a Phase II Single Center Prospective Clinical Trial
Sponsor:
Peking University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FOLFIRI-AEC2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
zhang xiaodong
Old Organization:
Peking University, School of Oncology, Department of GI oncology